About this Medicine article
445POverall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut): Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6) by Wu, Y.-L.; Sequist, L.V.; Schuler, M.; Yamamoto, N.; Zhou, C.; Hu, C.-P.; O'Byrne, K.; Hirsh, V.; Mok, T.; Zazulina, V.; Yang, J.C.-H. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Wu, Y.-L.; Sequist, L.V.; Schuler, M.; Yamamoto, N.; Zhou, C.; Hu, C.-P.; O'Byrne, K.; Hirsh, V.; Mok, T.; Zazulina, V.; Yang, J.C.-H.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)